Industrial Applications of Whole-Cell Biocatalysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industrial Applications of Whole-Cell Biocatalysis
Recombinant microbial whole-cell biocatalysis is a valuable approach for producing enantiomerically pure interemediates. The authors examine several groups of enzymes using this approach: dehydrogenases, hydantoinases, and acylases.


Pharmaceutical Technology


7. F. Cecere et al., "D-Carbamylamino Acids and Corresponding D-Amino Acids," Ger. Offen, 2,621, 076, Addn. to Ger. Offen. 2,422,737, Dec. 1976.

8. M. Kato, H. Kitagawa, and T. Miyoshi, "Microbial Racemization of Optically Active 5-Substituted Hydantions," Japanese Patent 62122591, 1987.

9. M. Pietzsch, C. Syldatk, and F. Wagner, "Isolation and Characterization of a New, Nonpyrioxal-5'-Phosphate Dependent Hydantion Racemase," DECHEMA Biotechnol. Conf. 4 (Pt A. Lect), 259–262 (1990).

10. C. Syldatk et al., "Microbial Hydantoinases—Industrial Enzymes from the Origin of Life?," Appl. Microbiol. Biotechnol. 51 (3), 293–309 (1999).

11. C. Gross, C. Syldatk, and F. Wagner, "Screening Method for Microorganisms Producing L-Amino Acids from D,L-5-Monosubstituted Hydantoins," Biotechnol. Tech. 1 (2) 85–90 (1987).

12. Y. Nishida et al., "Enzymatic Production of L-tryptophan from D,L-5-Indolylmethylhydantoin by Flavobacterium sp.," Enzyme Microb. Technol. 9 (12), 721–725 (1987).

13. D. Cotoras and F. Wagner, "Stereospecific Hydrolysis of 5-Monosubstituted Hydantoins," 3rd Eur. Congr. Biotechnol. 1, 351–356 (1984).

14. F. Wagner et al., "Microorganisms Producing L- Amino Acids, " German Patent DE 19519717, 1996

15. T. Wagner, B. Hantke, and F.J. Wagner, "Production of L-methionine from D,L-5-(2-methylthioethyl) Hydantoin by Resting Cells of a New Mutant Strain of Arthrobacter species DSM 7330," J. Biotechnol. 46 (1), 63–68 (1996).

16. O. May et al., "Substrate-Dependent Enantioselectivity of a Novel Hydantoinase from Arthrobacter aurescens DSM 3745: Purification and Characterization as New Member of Cyclic Amidases," J. Biotechnol. 61 (1) 1–13 (1998).

17. D. Volkel and F. Wagner, "Reaction Mechanism for the Conversion of 5-Monosubstituted Hydantoins to Enantiomerically Pure L-Amino Acids," Ann. N.Y. Acad. Sci., 750, 1–9 (1995).

18. O. May, P.T. Nguyen, and F.H. Arnold, "Inverting Enantioselectivity by Directed Evolution of Hydantoinase for Improved Production of L-Methionine," Nat. Biotechnol. 18 (3), 317–320 (2000).

19. A.S. Bommarius et al., "Operational Stability of Enzymes. Acylase-Catalyzed Resolution of N-Acetyl Amino Acids to Enantiomerically Pure L-Amino Acids," Ann. N. Y. Acad. Sci. 672, 126–136 (1992).

20. A.S. Bommarius, M. Schwarm, and K. Drauz, "The Membrane Reactor for the Acylase Process—From Laboratory Results to Commercial Scale," Chimica Oggi. 14 (10), 61–64 (1996).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here